RECEPTOR SUBTYPE AND FUNCTION SELECTIVE RETINOID AND REXINOID COMPOUNDS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY

• 收藏
• 分享

专利权人:

Inc.;IO Therapeutics

发明人:

Roshantha A. Chandraratna,Martin E. Sanders

申请号：

US15868391

公开号：

US20180133179A1

申请日:

2018.01.11

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Disclosed herein are methods for treating cancer comprising administering at least one immune checkpoint inhibitor and at least one Retinoic Acid Receptor or Retinoid X Receptor active agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/